Search by year - Any -2024202320222021202020192018201720162015 3 November 2020 Biocartis Announces Partnership with Endpoint Health to Develop Novel Companion Diagnostic in Critical Illness Non-regulated information 3 November 2020 Biocartis and GeneproDx To Collaborate on Fully Automated ThyroidPrint® test on Idylla™ Non-regulated information 29 October 2020 Biocartis and Exact Sciences Agree to End Collaboration Due to Changed Market Circumstances Inside information Regulated information 6 October 2020 Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™ Non-regulated information 1 October 2020 CORPORATE STATEMENT: Biocartis Joins COVID-19 Testing Industry Consortium of Nineteen Healthcare Community Organizations Non-regulated information 30 September 2020 Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay Non-regulated information 14 September 2020 Large Prospective Lung Cancer Study To Be Presented at ESMO Congress Shows Idylla™ Reduces EGFR Mutation Testing Turnaround Time by More than a Week Non-regulated information 1 September 2020 Biocartis Expands Collaboration with LifeArc Non-regulated information 26 June 2020 US Multicenter Study Shows Idylla™ Allows Rapid and Accurate Mutation Testing Results Across Different Laboratory Settings Non-regulated information 23 April 2020 Biocartis Announces Development of Idylla™ COVID-19 test Non-regulated information Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »